Management of Localized Pancreatic Cancer Current Treatment and Challenges /

This book is designed to present a comprehensive understanding for the rationale of neoadjuvant treatment sequencing for localized pancreatic cancer and to focus on accurate clinical staging and stage-specific treatment sequencing. Sections address important aspects of clinical management of localiz...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Tsai, Susan (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Ritch, Paul S. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Erickson, Beth A. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Evans, Douglas B. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
Έκδοση:1st ed. 2019.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04458nam a2200529 4500
001 978-3-319-98944-0
003 DE-He213
005 20191220125321.0
007 cr nn 008mamaa
008 190730s2019 gw | s |||| 0|eng d
020 |a 9783319989440  |9 978-3-319-98944-0 
024 7 |a 10.1007/978-3-319-98944-0  |2 doi 
040 |d GrThAP 
050 4 |a RD1-811 
072 7 |a MNC  |2 bicssc 
072 7 |a MED085000  |2 bisacsh 
072 7 |a MNC  |2 thema 
082 0 4 |a 617  |2 23 
245 1 0 |a Management of Localized Pancreatic Cancer   |h [electronic resource] :  |b Current Treatment and Challenges /  |c edited by Susan Tsai, Paul S. Ritch, Beth A. Erickson, Douglas B. Evans. 
250 |a 1st ed. 2019. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2019. 
300 |a X, 205 p. 55 illus., 47 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a The Future of Multidisciplinary Care in Pancreatic Cancer -- Clinical Staging of Pancreatic Adenocarcinoma with MDCT and MRI -- Coordination of Endoscopic Ultrasound-Guided FNA and Biliary Drainage in Pancreatic Cancer -- Importance of Carbohydrate Antigen 19-9 Monitoring in the Management of Pancreatic Cancer -- Treatment Sequencing for Resectable Disease -- Treatment Sequencing for Borderline Resectable Pancreatic Cancer -- Delivery of Neoadjuvant versus Adjuvant Therapy in Localized Pancreatic Cancer -- Neoadjuvant Therapy for Pancreatic Adenocarcinoma -- New Classification of Locally Advanced Pancreatic Cancer -- Treatment Sequencing for Locally Advanced Pancreatic Cancer -- Role of Radiation for Locally Advanced Pancreatic Cancer -- Molecular Profiling in Pancreatic Ductal Adenocarcinoma -- Genetic Counseling for Pancreatic Cancer -- Medical Nutrition Therapy throughout the Continuum of Care for Localized Pancreatic Cancer -- Role of 18F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Management of Pancreatic Cancer -- The New Bench for the Academic Surgeon: Precision Medicine. 
520 |a This book is designed to present a comprehensive understanding for the rationale of neoadjuvant treatment sequencing for localized pancreatic cancer and to focus on accurate clinical staging and stage-specific treatment sequencing. Sections address important aspects of clinical management of localized pancreatic cancer from diagnosis to surgery. These areas include initial radiographic staging, management of obstructive jaundice, role of chemotherapy and chemoradiation in neoadjuvant therapy, assessment of treatment response, and operative considerations for complex vascular resections. A brief review of suggested readings addressing the particular topic follows in each section, as well as a summary of clinical "pearls". Management of Localized Pancreatic Cancer: Current Treatment and Challenges provides a comprehensive resource which clearly defines the principles of neoadjuvant therapy as well as a clinical framework for successful therapy. It serves as a valuable guide to physicians of multiple disciplines who are interested in utilizing neoadjuvant therapy for localized pancreatic cancer. 
650 0 |a Surgery. 
650 0 |a Surgical oncology. 
650 0 |a Oncology  . 
650 0 |a Radiotherapy. 
650 1 4 |a General Surgery.  |0 http://scigraph.springernature.com/things/product-market-codes/H59044 
650 2 4 |a Surgical Oncology.  |0 http://scigraph.springernature.com/things/product-market-codes/H59150 
650 2 4 |a Oncology.  |0 http://scigraph.springernature.com/things/product-market-codes/H33160 
650 2 4 |a Radiotherapy.  |0 http://scigraph.springernature.com/things/product-market-codes/H29056 
700 1 |a Tsai, Susan.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Ritch, Paul S.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Erickson, Beth A.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Evans, Douglas B.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319989433 
776 0 8 |i Printed edition:  |z 9783319989457 
856 4 0 |u https://doi.org/10.1007/978-3-319-98944-0  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)